Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity

Second-Generation Corticosteroids for the Treatment of Crohn’s Disease and Ulcerative Colitis: More Effective and Less Side Effects?

(2012) Chiara De Cassan et al.   DIGESTIVE DISEASES

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Topical Delivery of Steroids in Inflammatory Bowel Disease

(2012) C. Girlich et al.   Current Drug Delivery

Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial

(2011) Cosimo Prantera et al.   DIGESTIVE AND LIVER DISEASE

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

(2010) Andreas Tromm et al.   GASTROENTEROLOGY

A retrospective study on a cohort of patients with lymphocytic colitis

(2010) D. Simondi et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Budesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study

(2009) Stephan Miehlke et al.   GASTROENTEROLOGY

World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010

(2009) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9mg extended-release tablets in patients with active left-sided ulcerative colitis

(2009) G.R. D'Haens et al.   Journal of Crohns & Colitis

Oral budesonide for maintenance of remission of Crohn’s disease: a pooled safety analysis

(2008) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Steroid-refractory ulcerative colitis: Predictive factors of response to cyclosporine and validation in an independent cohort

(2007) Montserrat Aceituno et al.   INFLAMMATORY BOWEL DISEASES